Loading...
Idera Pharmaceuticals, Inc.
IDRA•NASDAQ
Healthcare
Biotechnology
$0.42
$-0.13(-23.04%)

Idera Pharmaceuticals, Inc. (IDRA) Balance Sheet Analysis
Idera Pharmaceuticals, Inc. (IDRA) manages its money wisely, with plenty of N/A and N/A to cover its bills. The company’s long-term debts are manageable, balanced by steady 0.00%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a stable position, giving it room to invest, expand, or adapt. For investors, this paints a steady picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan